Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy regulation using luteolin: new insight into its anti-tumor activity
Milad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 138
Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
Shuang Chai, Yanbing Yang, Liwei Wei, et al.
Phytomedicine (2024) Vol. 128, pp. 155516-155516
Open Access | Times Cited: 21
Neuroprotective mechanisms of luteolin in glutamate-induced oxidative stress and autophagy-mediated neuronal cell death
Wudtipong Vongthip, Sunita Nilkhet, Kanokkan Boonruang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Revisiting luteolin: An updated review on its anticancer potential
Abdur Rauf, Polrat Wilairatana, Payal B. Joshi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26701-e26701
Open Access | Times Cited: 18
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 17
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 102
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 155-176
Open Access | Times Cited: 101
Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex
Shiyuan Wang, Tulake Wuniqiemu, Wei‐Feng Tang, et al.
International Immunopharmacology (2021) Vol. 94, pp. 107460-107460
Closed Access | Times Cited: 86
Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
Nada Oršolić, Maja Jazvinšćak Jembrek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10479-10479
Open Access | Times Cited: 61
Luteolin: a flavonoid with a multifaceted anticancer potential
Parteek Prasher, Mousmee Sharma, Sachin Kumar Singh, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 54
Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives
Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5373-5373
Open Access | Times Cited: 51
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
Mingyi Shi, Zixian Chen, Hui Gong, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 880-911
Closed Access | Times Cited: 29
Flavonoids as promising molecules in the cancer therapy: An insight
Suhail Ahmad Mir, Ashraf Dar, Laraibah Hamid, et al.
Current Research in Pharmacology and Drug Discovery (2023) Vol. 6, pp. 100167-100167
Open Access | Times Cited: 28
Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
Dan Liu, Hongtao Zhu, Chuanzhou Li
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling
Ling Wu, Yingda Lin, Songyu Gao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
Juwon Lee, Youngjin Han, Wenyu Wang, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 48
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
Sepideh Mirzaei, Mohammad Gholami, Hui Li Ang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3348-3348
Open Access | Times Cited: 44
Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2007-2007
Open Access | Times Cited: 41
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions
Mahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, et al.
Cellular Signalling (2022) Vol. 94, pp. 110323-110323
Closed Access | Times Cited: 30
Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance
Ming Han, Yuting Lu, Yunhua Tao, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 975-975
Open Access | Times Cited: 18
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
Mukta Gupta, Javed Ahmad, Javed Ahamad, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5159-5192
Closed Access | Times Cited: 15
Autophagy-related biomarkers in preeclampsia: the underlying mechanism, correlation to the immune microenvironment and drug screening
Rui Wan, Peng Yao, Yuxiu Wang, et al.
BMC Pregnancy and Childbirth (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
D-α-tocopherol polyethylene glycol 1000 succinate-based microemulsion delivery system: Stability enhancement of physicochemical properties of luteolin
Yimei Zheng, Chengang Zhao, Boyu Chen, et al.
Food Chemistry (2023) Vol. 426, pp. 136587-136587
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top